Director
Daiichi Sankyo, Inc.
Basking Ridge, New Jersey
Xinyuan (Susie) Zhang, Ph.D., is a Director of Quantitative Clinical Pharmacology at Daiichi Sankyo, Inc. (DSI). Prior to joining DSI, she was a physiologically based pharmacokinetic (PBPK) co-lead in the Division of Pharmacometrics (DPM), Office of Clinical Pharmacology (OCP), US Food & Drug Administration (US FDA), where she provided scientific oversight for PBPK review and research activities in OCP. Dr. Zhang conducted clinical pharmacology reviews for numerous Investigational New Drug (IND) applications and New Drug Applications (NDAs), and participated in several clinical pharmacology related guidance development during her tenure at the OCP. Prior to joining OCP, Dr. Zhang was a scientific lead for absorption modeling in the Office of Generic Drugs (OGD), US FDA, where she focused on applying PBPK absorption modeling and simulation to address scientific issues in generic drug product review and guidance development. She received her Ph.D. from the University of Michigan, Ann Arbor.
Disclosure information not submitted.
Tuesday, October 18, 2022
8:30 AM – 9:00 AM ET